275 related articles for article (PubMed ID: 32084383)
1. Mitigating biotin interference in two Roche immunoassays by premixing biotinylated capturing molecules with streptavidin coated beads.
Yang J; Wiencek JR
Clin Chim Acta; 2020 Jun; 505():130-135. PubMed ID: 32084383
[TBL] [Abstract][Full Text] [Related]
2. Mitigation of Biotin Interference in Manual and Automated Immunoassays by Preconjugating Biotinylated Antibodies to the Streptavidin Surface as an Alternative to Biotin Depletion.
Nelson HA; La'ulu SL; Lu J; Doyle K
J Appl Lab Med; 2022 May; 7(3):762-775. PubMed ID: 35018420
[TBL] [Abstract][Full Text] [Related]
3. Biotin interference in immunoassays based on biotin-strept(avidin) chemistry: An emerging threat.
Luong JHT; Male KB; Glennon JD
Biotechnol Adv; 2019; 37(5):634-641. PubMed ID: 30872068
[TBL] [Abstract][Full Text] [Related]
4. Depletion of biotin using streptavidin-coated microparticles: a validated solution to the problem of biotin interference in streptavidin-biotin immunoassays.
Trambas C; Lu Z; Yen T; Sikaris K
Ann Clin Biochem; 2018 Mar; 55(2):216-226. PubMed ID: 28406314
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive assessment of biotin interference in immunoassays.
Li J; Wagar EA; Meng QH
Clin Chim Acta; 2018 Dec; 487():293-298. PubMed ID: 30296442
[TBL] [Abstract][Full Text] [Related]
6. Characterization of biotin interference in 21 Vitros 5600 immunoassays and risk mitigation for patient safety at a large academic medical center.
Stieglitz HM; Korpi-Steiner N
Clin Biochem; 2020 Jan; 75():53-61. PubMed ID: 31677994
[TBL] [Abstract][Full Text] [Related]
7. Interference of anti-streptavidin antibodies: More common than we thought? In relation to six confirmed cases.
Ricci V; Esteban MP; Sand G; Menises MM
Clin Biochem; 2021 Apr; 90():62-65. PubMed ID: 33545112
[TBL] [Abstract][Full Text] [Related]
8. Association of Biotin Ingestion With Performance of Hormone and Nonhormone Assays in Healthy Adults.
Li D; Radulescu A; Shrestha RT; Root M; Karger AB; Killeen AA; Hodges JS; Fan SL; Ferguson A; Garg U; Sokoll LJ; Burmeister LA
JAMA; 2017 Sep; 318(12):1150-1160. PubMed ID: 28973622
[TBL] [Abstract][Full Text] [Related]
9. Apparent Hyperthyroidism Caused by Biotin-Like Interference from IgM Anti-Streptavidin Antibodies.
Lam L; Bagg W; Smith G; Chiu WW; Middleditch MJ; Lim JC; Kyle CV
Thyroid; 2018 Aug; 28(8):1063-1067. PubMed ID: 29808739
[TBL] [Abstract][Full Text] [Related]
10. BIOTIN INTERFERENCE WITH ROUTINE CLINICAL IMMUNOASSAYS: UNDERSTAND THE CAUSES AND MITIGATE THE RISKS.
Samarasinghe S; Meah F; Singh V; Basit A; Emanuele N; Emanuele MA; Mazhari A; Holmes EW
Endocr Pract; 2017 Aug; 23(8):989-998. PubMed ID: 28534685
[TBL] [Abstract][Full Text] [Related]
11. The biotin interference within interference suppressed immunoassays.
Kabiri P; Weiskirchen R; van Helden J
J Clin Lab Anal; 2021 Sep; 35(9):e23940. PubMed ID: 34346119
[TBL] [Abstract][Full Text] [Related]
12. AACC Guidance Document on Biotin Interference in Laboratory Tests.
Li D; Ferguson A; Cervinski MA; Lynch KL; Kyle PB
J Appl Lab Med; 2020 May; 5(3):575-587. PubMed ID: 32445355
[TBL] [Abstract][Full Text] [Related]
13. Matrix interference in serum total thyroxin (T4) time-resolved fluorescence immunoassay (TRFIA) and its elimination with the use of streptavidin-biotin separation technique.
Wu FB; He YF; Han SQ
Clin Chim Acta; 2001 Jun; 308(1-2):117-26. PubMed ID: 11412823
[TBL] [Abstract][Full Text] [Related]
14. False biochemical diagnosis of hyperthyroidism in streptavidin-biotin-based immunoassays: the problem of biotin intake and related interferences.
Piketty ML; Polak M; Flechtner I; Gonzales-Briceño L; Souberbielle JC
Clin Chem Lab Med; 2017 May; 55(6):780-788. PubMed ID: 27732554
[TBL] [Abstract][Full Text] [Related]
15.
Ghosh A; Russell A; Dasgupta A
Ann Clin Lab Sci; 2022 May; 52(3):504-506. PubMed ID: 35777806
[TBL] [Abstract][Full Text] [Related]
16. Determination of the affinity constant of streptavidin-coupled magnetic particles and a biotinylated antibody for high performance of magnetic solid carrier in immunoassays.
Dai X; Xu H; Zhang X; Zhu W; Gu H; Wei M
Mater Sci Eng C Mater Biol Appl; 2014 Jan; 34():422-8. PubMed ID: 24268278
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the scope and magnitude of biotin interference in susceptible Roche Elecsys competitive and sandwich immunoassays.
Trambas C; Lu Z; Yen T; Sikaris K
Ann Clin Biochem; 2018 Mar; 55(2):205-215. PubMed ID: 28875734
[TBL] [Abstract][Full Text] [Related]
18. High-dose biotin therapy leading to false biochemical endocrine profiles: validation of a simple method to overcome biotin interference.
Piketty ML; Prie D; Sedel F; Bernard D; Hercend C; Chanson P; Souberbielle JC
Clin Chem Lab Med; 2017 May; 55(6):817-825. PubMed ID: 28222020
[TBL] [Abstract][Full Text] [Related]
19. Novel application of streptavidin-hapten derivatives as protein-tracer conjugate in competitive-type immunoassays involving biotinylated detection probes.
Khosravi MJ; Morton RC
Clin Chem; 1991 Jan; 37(1):58-63. PubMed ID: 1988210
[TBL] [Abstract][Full Text] [Related]
20. Nets of biotin-derived gold nanoparticles as a label for the C-reactive protein immunoassay.
Kokorina AA; Rashchevskaya RO; Goryacheva IY
Anal Bioanal Chem; 2021 Nov; 413(27):6867-6875. PubMed ID: 34559243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
